Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2025-12-26 @ 11:47 AM
NCT ID:
NCT02207816
Eligibility Criteria:
Inclusion Criteria:
* Subjects' parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Subjects who were enrolled and who received at least one vaccine dose in the primary study MALARIA-055 PRI NCT00866619 and who did not withdraw consent (except those who moved away from the area) during the primary study MALARIA-055 PRI NCT00866619.
* Written informed consent obtained from the parent(s)/LAR(s) of the subject.
Exclusion Criteria:
* Child in care.
* Use of any investigational or non-registered product or planned use during the study period.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
42 Months
Maximum Age:
9 Years
Study:
NCT02207816
Study Brief:
Protocol Section:
NCT02207816